Hepatitis G viral RNA in serum and in peripheral blood mononuclear cells and its relation to HCV-RNA in patients with clotting disorders

Thrombosis and Haemostasis

Volumn 77, Issue 5, 1997, Pages 868-872

  Sheng, Li ^a   Soumillion, Ann ^a   Peerlinck, Kathelijne ^a   Verslype, Chris ^a   Lin, Lan ^a   Van Pelt, Jos ^a   Hess, Georg ^b   Vermylen, Jozef ^a   Yap, Sing Hiem ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD DONOR; CHILD; CONTROLLED STUDY; FEMALE; FLAVIVIRUS; GENOTYPE; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HEPATITIS VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIREMIA; VIRUS INFECTION;

EID: 0031011575     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1656069     Document Type: Article

References (20)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
2. Kuo G, Choo QL, Alter HJ, Gitnik GL, Redeker AG, Purcell RH, Miyamura T Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
3. Houghton M, Weiner A, Han J, Kuo G, Choo QL. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral diseases. Hepatology 1991; 14: 381-8.
4. Donahue JG, Munoz A, Ness PM Brown DE, Yawn DH, Mc Allister HA, Reitz BA. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
5. Linnen J, Wages J Jr, Zhang-Keck Z-Y, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyalnis S, Karayiannis P, Fung K, Nakatsuj Y, Shih JW-K, Young L, Piatak M Jr, Hoover C, Fernandez J, Chen S, Zou J-C, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Founc SKH, Thomas H, Bradley D, Margolis H, Kim JP. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-8.
6. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK. Isolation of novel virus-like sequence associated with human hepatitis. Nat Med 1995; 1: 564-9.
7. Simons JN Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL. Identification of two flavivirus-like genome in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-5.
8. Schmidt B, Korn K, Fieckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet 1996; 347: 908.
9. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, Inoue T, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334:1485-90.
10. Willems M, Peerlinck K, Moshage H, Deleu I, Van den Eynde C, Vermylen J Yap SH. Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells. J Med Virol 1994; 42: 272-8.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem 1987; 162:156-9.
12. Sheng L, Willems M, Peerlinck K, Vermylen J, Yap SH. Hepatitis C virus genotypes in Belgian hemophiliacs. J Med Virol 1995; 45: 211-4.
13. Czaja AJ, Carpenter HA, Santrach PJ, Breanndan M, Hombuger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterol 1993; 104: 1755-61.
14. Kudali VP, Gordon SC, Silverman AL, McCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B and non-C hepatitis. Am J Gastroenterol 1994; 89: 1836-9.
15. Nübling CM, Löwer J. GB-C genomes in a high-risk group, in plasma pools, and in intravenous immunoglobulin. Lancet 1996; 347: 68.
16. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 344:195-6.
17. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-2.
18. Heringlake S, Osterkamp S, Trauwein C, Tillmann HL, Böker K, Muerhoff S, Mushahwar IK, Hunsmann G, Manns MP. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-9.
19. Jarvis LM, Davidso F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-5.
20. Garcia-Trevijano ER, López-Alcorocho JM, Quintana M, Hernández F, Carreno V. HGV in coagulation-factor concentrates. Lancet 1996; 348: 1032.